Oncopeptides Partners with Veeva to Drive More Effective Engagement Ahead of First Commercial Launch
PLEASANTON, Calif., May 17, 2021 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a strateg... See more »
5 Followers on Owler
Oncopeptides
Oncopeptides is a pharmaceutical company that develops and commercializes therapies for the treatment of hematological cancer. Read more
CEO
Marty J Duvall
Missing a competitor? Contribute!
Cellectis is a top competitor of Oncopeptides. Cellectis was founded in 1999, and is headquartered in New York, New York. Cellectis is in the Biotechnology industry. Cellectis generates $82.5M more revenue vs. Oncopeptides.
Weigh-in!
Help the Owler community know moreOncopeptides Quarterly and Annual Revenue
Coming soon for Oncopeptides!
Annual Revenue
Oncopeptides Acquisitions
No recent acquisitions found related to Oncopeptides
Oncopeptides Funding History
Since Oncopeptides was founded in 2000, it has participated in 1 round of funding. In total Oncopeptides has raised $47.1M. Oncopeptides' funding round was on Oct 2020 for a total of $47.1M
ROUND
FUNDING DATE
AMOUNT
INVESTORS
Debt
Oct 2020
$47.1M
European Investment Bank
Since Oncopeptides was founded in 2000, it has participated in 1 round of funding. In total Oncopeptides has raised $47.1M. Oncopeptides' funding round was on Oct 2020 for a total of $47.1M
Oncopeptides Investments
No recent investments found related to Oncopeptides
Oncopeptides News
May 17, 2021Markets Insider
May 12, 2021FinanzNachrichten
Oncopeptides presents new clinical and preclinical melflufen data at the upcoming European Hematology Association meeting
STOCKHOLM, May 12, 2021 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global bio... See more »
May 5, 2021Drug Delivery Business
Oncopeptides completes enrollment in Phase 2 multiple myeloma study
Oncopeptides announced today that it completed patient enrollment for its Phase 2 Port study of its m... See more »
April 26, 2021BioSpace
Oncopeptides publishes the 2020 Annual Report
Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development ... See more »
April 26, 2021BioSpace
Annual General Meeting in Oncopeptides AB (publ) - Apr 26, 2021
The shareholders in Oncopeptides AB, reg. no. 556596-6438, with registered office in the municipality... See more »
April 17, 2021Pharmabiz
Oncopeptides seeks European marketing approval for melflufen to treat r/r multiple myeloma
Oncopeptides, a global biotech company, announced that the company has submitted an application to th... See more »
April 16, 2021Drug Delivery Business
Oncopeptides seeks EU marketing authorization for multiple myeloma treatment
Oncopeptides announced today that it submitted an application for European marketing authorization of... See more »
Oncopeptides Press Releases
October 2, 2020EIN Presswire
Lazarex Cancer Foundation and Oncopeptides Partner to Remove Financial Barriers to Oncopeptides' sEAPort Expanded Access
This Marks the First Innovative Partnership between Lazarex and a Pharmaceutical Company for this Pur... See more »
September 4, 2020StreetInsider
Oncopeptides completes the extended enrollment for the pivotal phase 3 OCEAN study in relapsed refractory multiple myeloma - 495 patients included
STOCKHOLM, Sept. 4, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announ... See more »
June 15, 2020Cision
Oncopeptides reports positive results from full data set of Phase 2 HORIZON trial in triple-class refractory multiple myeloma patients
STOCKHOLM - June 15, 2020 - Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that the full... See more »
March 24, 2020centralcharts
The Lancet Haematology Publishes Results From Oncopeptides' Multicenter, International Phase 1/2 Study (O-12-M1)
The Lancet Haematology Publishes Results From Oncopeptides' Multicenter, International Phase 1/2 Stud... See more »
September 24, 2019centralcharts
Exercise of Options and Sale of Shares Under the Employee Stock Option Program 2012/2019
Exercise of Options and Sale of Shares Under the Employee Stock Option Program 2012/2019 PR Newswire ... See more »
September 11, 2019PR Newswire
Data From Oncopeptides Melflufen Clinical Development Program Presented at SOHO 2019 Annual Meeting
STOCKHOLM, Sept. 11, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today th... See more »
Social Media
Oncopeptides Headquarters
Trending Companies
IN THE NEWS
Roper Technologies | Endeavour Silver | Greif | Arco Platform | McLane | Kraft Heinz | Virginia Union University | Weatherford | Domino's Pizza | Akamai | U.S. Bank | RealMe | Gilead | Progressive | Cohbar | Fastenal | Turquoise Hill | AbbVie | Spotlight Brands | MyoKardia | Baxter | POOLCORP | Teamworthy | Rocky Mountain High Brands | Marsh & McLennan | VRR | ICICI Securities | Coastal Federal Credit Union | Lipocine | Norfolk Southern | Discover | SBI | Corbus Pharmaceuticals | Allstate | Ralph Lauren | M&T Bank | Industrial Adhesive Solutions | IWP | Bloomingdale's | Marriott | Cohen & Steers | Kensington Mortgages | iLOOKABOUT | GoodRx | TE Connectivity | Gnusbrands | Pebblebrook Hotel | 3M | Verisk | P&G
PEOPLE ALSO VIEWED
Crucell | Hycult Biotech | Lifetein | Cellectar | BioProcess Algae | GAVIS Pharmaceuticals | Anandia Labs | Senomyx | Lyell | Ed-Diagnosis, Net | Trans Ova Genetics | FloDesign Sonics | OWL Metabolomics | Fluorish | NeRRe Therapeutics | Us Xpress Drivers | Dominion Partners, L.C. | BioFocus | Reiko Wireless Inc | Northpoint | Enbitec Waste Management Services | Drugabilis | National Pharmacy | Cytognomix | Goherogo | GTI Capital Group | Symphony Eyc | Kelowna Newcomers Alumni Society | Downingusa | Funda in business
Oncopeptides Summary
ABOUT
Overview
Oncopeptides is a pharmaceutical company that develops and commercializes therapies for the treatment of hematological cancer. Oncopeptides was founded in 2000. Oncopeptides' headquarters is located in Stockholm, Stockholms län, SE 111 37. It has rais...
CEO
Oncopeptides's CEO, Marty J Duvall, currently has an approval rating of 90%. Oncopeptides's primary competitors are Cellectis, OncoImmune & Amphivena.Website
oncopeptides.seFrequently Asked Questions about Oncopeptides
When was Oncopeptides founded?
Oncopeptides was founded in 2000Who is Oncopeptides's CEO?
Oncopeptides's CEO is Marty J DuvallHow much revenue does Oncopeptides generate?
Oncopeptides generates $ < 1M in revenueHow much funding does Oncopeptides have?
Oncopeptides has historically raised $47.1M in funding
Where is Oncopeptides's headquarters?
Oncopeptides's headquarters is in Stockholm Stockholms län, SEHow many employees does Oncopeptides have?
Oncopeptides has 88 employeesWhat sector does Oncopeptides operate in?
Oncopeptides is in PharmaceuticalsWho are Oncopeptides's competitors?
Oncopeptides's top competitors are Cellectis, OncoImmune, Amphivena
